Company Information

CIAN HEALTHCARE LTD.

NSE : NABSE : 542678ISIN CODE : INE05BN01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE21.31-0.48 (-2.2 %)
PREV CLOSE ( ) 21.79
OPEN PRICE ( ) 21.79
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 74000
TODAY'S LOW / HIGH ( )20.92 22.55
52 WK LOW / HIGH ( ) 16.0541.1
NSE
This Company is not listed in NSE
Managing DirectorSuraj Zanwar
Company SecretaryMunjaji Dhumal
Non Executive DirectorParesh Arun Shah
Non Executive Independent DirectorSwati Maheshwari
Sunil Saini
Incorporation Year : 07-01 2003

Registered Office :

Address : Milkat No . 3339 , Block No . 1, From South Side,C . S . No . 227 /2 + 3 A, Harpale Park,Opp Berger Paint , Phursungi , Tal . Haveli Pune,
Maharashtra-412308 .

Phone : 020-26982792

Email :  cs@cian.co 

URL : www.cian.co

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.